To PARP or Not to PARP -- What Is the Question? Part 2.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 7, p. 413
- By:
- Publication type:
- Article
Works matching IS 21660166 AND DT 2013 AND VI 2 AND IP 7
Results: 22
1
2
Personalizing Therapy in the Management of Recurrent Non-Small Cell Lung Cancer: Case Study of a Patient With an EGFR Mutation.
- Published in:
- 2013
- Publication type:
- Case Study
3
Role of Radiation and Imaging in DCIS Explained.
- Published in:
- 2013
- Publication type:
- Proceeding
4
Molecular Proiling in Breast Cancer: Still Not Ready for the Clinic.
- Published in:
- 2013
- Publication type:
- Proceeding
5
Multiplex Genetic Assays Identify Mutations Beyond BRCA1/2 in 10% of Patients at Risk for Breast Cancer.
- Published in:
- 2013
- Publication type:
- Proceeding
6
Pharmacologic Considerations in the Transplant Setting for Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 7, p. 401
- By:
- Publication type:
- Article
7
Patient-Centered Nursing Care in the Transplant Setting.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 7, p. 399
- By:
- Publication type:
- Article
8
The Role of Transplantation in Improving Patient Outcomes in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 7, p. 397
- By:
- Publication type:
- Article
9
LETTER FROM THE EDITOR-IN-CHIEF.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 7, p. 396
- By:
- Publication type:
- Article
10
Highlights from EHA 2013.
- Published in:
- 2013
- Publication type:
- Proceeding
11
LETTER FROM THE EDITOR.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 7, p. 388
- By:
- Publication type:
- Article
12
Multiple Myeloma and the MMRF CoMMpass Study: Revolutionizing Clinical Trial Data Dissemination.
- Published in:
- 2013
- By:
- Publication type:
- Interview
13
Bench to Bedside, Gene to Drug Discovery Defines New Era of Precision Medicine.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
14
Gene Expression Tests Using Bronchial, Nasal Epithelium Under Development for Early Detection of Lung Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
15
Personalized Cancer Treatment: Combination Therapies May Be Key to Hitting Tumor Heterogeneity.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
16
Practical Problems Must Be Overcome to Move Personalized Medicine Forward in Oncology.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
17
Understanding Molecular Subtypes Is Basis for Genomic Medicine in Prostate Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
18
VA Takes Lead Role in Using Informatics to Validate and Translate Biomarkers.
- Published in:
- 2013
- Publication type:
- Proceeding
19
Next-Generation Sequencing Identifies Actionable Genomic Alterations in Solid Tumors.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
20
Biomarker Development and Validation Crucial to Use of Emerging Treatments in Solid Tumors and Hematologic Malignancies.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
21
Redesigning Clinical Trials Necessary to Improve Odds of Finding Effective Targeted Agents in the Genomic Era.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
22
PMO Proudly Announces Dr Sanjiv S. Agarwala to Join Dr Al Benson as Co-Editor in Chief.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 7, p. 364
- Publication type:
- Article